z-logo
open-access-imgOpen Access
The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis
Author(s) -
Minal Chaudhary,
Shree Bajaj,
Shruti Bohra,
Nisu Swastika,
Alka Hande
Publication year - 2015
Publication title -
journal of oral and maxillofacial pathology/journal of oral and maxillofacial pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.455
H-Index - 25
eISSN - 1998-393X
pISSN - 0973-029X
DOI - 10.4103/0973-029x.164519
Subject(s) - oral submucous fibrosis , pathology , malignant transformation , epithelial dysplasia , precancerous condition , dysplasia , immunohistochemistry , carcinogenesis , fibrosis , medicine , tramp , hypoxia (environmental) , metastasis , cancer , biology , adenocarcinoma , chemistry , organic chemistry , oxygen
Oral submucous fibrosis (OSMF) is a precancerous condition predominantly seen in people of Asian descent. About 7-12% OSMF patients develop oral squamous cell carcinoma (OSCC). Morphological features of OSMF especially fibrosis suggests a possibility of the hypoxic environment in diseased tissues. Oral cancer usually develops from hyperplasia through dysplasia to carcinoma. Neovascularization and increased glycolysis, represent adaptations to a hypoxic microenvironment that are correlated with tumor invasion and metastasis. The adaptation of cells to hypoxia appears to be mediated via hypoxia inducible factor-1α (HIF-1α). HIF-1α is said to be associated with malignant transformation of epithelium in other sites. It appears that HIF-1α plays a significant role in both prostate and cervical carcinogenesis at early stages. We hypothesize that progression of OSMF and malignant transformation in the background of fibrosis mediates via HIF-1α either by up- or down-regulation of various such molecules. Therefore, the main objective of this study was to investigate the relationship between the expression of HIF-1α in OSMF, OSCC and OSCC with OSMF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here